Regulation of activity and function of the p52 NF-κB subunit following DNA damage

Cell Cycle

Volumn 9, Issue 24, 2010, Pages 4795-4804

  Barr, Benjamin ^a   Coqueret, Olivier ^a   Perkins, Neil D ^b  

^a Groupe Cytokines et Récepteurs   (France)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Alternative pathway; ATM; DNA damage; IKK ; NEMO; NF B; p52; p53

Indexed keywords

ATM PROTEIN; I KAPPA B KINASE ALPHA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P100; PROTEIN P53;

ADAPTIVE IMMUNITY; ARTICLE; CELL CYCLE ARREST; CELL DEATH; CHROMATIN IMMUNOPRECIPITATION; DNA DAMAGE; FEEDBACK SYSTEM; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; PROTEIN FUNCTION;

ATAXIA TELANGIECTASIA;

EID: 78650380225     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.24.14245     Document Type: Article

References (40)

1. Kim HJ, Hawke N, Baldwin AS. NF-κB and IKK as therapeutic targets in cancer. Cell Death Differ 2006; 13:738-47.
2. Bender K, Gottlicher M, Whiteside S, Rahmsdorf HJ, Herrlich P. Sequential DNA damage-independent and -dependent activation of NF-κB by UV. EMBO J 1998; 17:5170-81.
3. Janssens S, Tschopp J. Signals from within: the DNA-damage-induced NF-κB response. Cell Death Differ 2006; 13:773-84.
4. Kato T Jr, Delhase M, Hoffmann A, Karin M. CK2 Is a C-Terminal I-κB Kinase Responsible for NF-κB Activation during the UV Response. Mol Cell 2003; 12:829-39.
5. Wu ZH, Miyamoto S. Induction of a pro-apoptotic ATM-NF-κB pathway and its repression by ATR in response to replication stress. EMBO J 2008; 27:1963-73.
6. Wu ZH, Miyamoto S. Many faces of NF-κB signaling induced by genotoxic stress. J Mol Med 2007; 85:1187-202.
7. Stilmann M, Hinz M, Arslan SC, Zimmer A, Schreiber V, Scheidereit C. A nuclear poly(ADPribose)- dependent signalosome confers DNA damage- induced I-κB kinase activation. Mol Cell 2009; 36:365-78.
8. Tsuchiya Y, Asano T, Nakayama K, Kato T Jr, Karin M, Kamata H. Nuclear IKKβ is an adaptor protein for I-κBα ubiquitination and degradation in UV-induced NF-κB activation. Mol Cell 2010; 39:570-82.
9. Wu ZH, Wong ET, Shi Y, Niu J, Chen Z, Miyamoto S, et al. ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. Mol Cell 2010; 40:75-86.
10. Huang J, Teng L, Liu T, Li L, Chen D, Li F, et al. Identification of a novel serine/threonine kinase that inhibits TNF-induced NF-κB activation and p53-induced transcription. Biochem Biophys Res Commun 2003; 309:774-8.
11. Li M, Shillinglaw W, Henzel WJ, Beg AA. The Rela(p65) subunit of NF-κB is essential for inhibiting double-stranded RNA-induced cytotoxicity. J Biol Chem 2001; 276:1185-94.
12. Piret B, Schoonbroodt S, Piette J. The ATM protein is required for sustained activation of NF-κB following DNA damage. Oncogene 1999; 18:2261-71.
13. Wu ZH, Shi Y, Tibbetts RS, Miyamoto S. Molecular linkage between the kinase ATM and NF-κB signaling in response to genotoxic stimuli. Science 2006; 311:1141-6.
14. Janssens S, Tinel A, Lippens S, Tschopp J. PIDD mediates NF-κB activation in response to DNA damage. Cell 2005; 123:1079-92.
15. Mabb AM, Wuerzberger-Davis SM, Miyamoto S. PIASy mediates NEMO sumoylation and NF-κB activation in response to genotoxic stress. Nat Cell Biol 2006; 8:986-93.
16. Barre B, Perkins ND. A cell cycle regulatory network controlling NF-κB subunit activity and function. EMBO J 2007; 26:4841-55.
17. Schumm K, Rocha S, Caamano J, Perkins ND. Regulation of p53 tumour suppressor target gene expression by the p52 NF-κB subunit. EMBO J 2006; 25:4820-32.
18. Barre B, Perkins ND. The Skp2 promoter integrates signaling through the NF-κB, p53 and Akt/GSK3β pathways to regulate autophagy and apoptosis. Mol Cell 2010; 38:524-38.
19. Xiao G, Fong A, Sun SC. Induction of p100 processing by NF-κB-inducing kinase involves docking I-κB kinase α (IKKα) to p100 and IKKα-mediated phosphorylation. J Biol Chem 2004; 279:30099-105.
20. Rocha S, Garrett MD, Campbell KJ, Schumm K, Perkins ND. Regulation of NF-κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J 2005; 24:1157-69.
21. Lombardi L, Ciana P, Cappellini C, Trecca D, Guerrini L, Migliazza A, et al. Structural and functional characterization of the promoter regions of the NFKB2 gene. Nucleic Acids Res 1995; 23:2328-36.
22. Liptay S, Schmid RM, Nabel EG, Nabel GJ. Transcriptional regulation of NFkB2: evidence for -κB-mediated positive and negative autoregulation. MolCellBiol 1994; 14:7695-703.
23. Basak S, Kim H, Kearns JD, Tergaonkar V, O'Dea E, Werner SL, et al. A fourth I-κB protein within the NF-κB signaling module. Cell 2007; 128:369-81.
24. Campbell KJ, O'Shea JM, Perkins ND. Differential regulation of NF-κB activation and function by topoisomerase II inhibitors. BMC Cancer 2006; 6:101.
25. Campbell KJ, Perkins ND. Reprogramming RelA. Cell Cycle 2004; 3:869-72.
26. Campbell KJ, Rocha S, Perkins ND. Active repression of antiapoptotic gene expression by RelA(p65) NF-κB. Mol Cell 2004; 13:853-65.
27. Campbell KJ, Witty JM, Rocha S, Perkins ND. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-κB transactivation. Cancer Res 2006; 66:929-35.
28. Karl S, Pritschow Y, Volcic M, Hacker S, Baumann B, Wiesmuller L, et al. Identification of a novel proapopotic function of NF-κB in the DNA damage response. J Cell Mol Med 2009; 13:4239-56.
29. Strozyk E, Poppelmann B, Schwarz T, Kulms D. Differential effects of NF-κB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome. Oncogene 2006; 25:6239-51.
30. Rocha S, Campbell KJ, Perkins ND. p53- and Mdm2-independent repression of NF-κB transactivation by the ARF tumor suppressor. Mol Cell 2003; 12:15-25.
31. Rocha S, Perkins ND. ARF the integrator: linking NF-κB, p53 and checkpoint kinases. Cell Cycle 2005; 4:756-9.
32. Luo X, He Q, Huang Y, Sheikh MS. Transcriptional upregulation of PUMA modulates endoplasmic reticulum calcium pool depletion-induced apoptosis via Bax activation. Cell Death Differ 2005; 12:1310-8.
33. Rocha S, Martin AM, Meek DW, Perkins ND. p53 represses cyclin D1 transcription through downregulation of Bcl-3 and inducing increased association of the p52 NF-κB subunit with histone deacetylase 1. Mol Cell Biol 2003; 23:4713-27.
34. Senftleben U, Cao YX, Xiao GT, Greten FR, Krahn G, Bonizzi G, et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 2001; 293:1495-9.
35. Ak P, Levine AJ. p53 and NF-κB: different strategies for responding to stress lead to a functional antagonism. FASEB J 2010; 24:3643-52.
36. Dey A, Tergaonkar V, Lane DP. Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways. Nat Rev Drug Discov 2008; 7:1031-40.
37. Perkins ND. Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 2007; 8:49-62.
38. Barre B, Perkins ND. Phosphorylation of the p52 NF-κB subunit. Cell Cycle This edition.
39. O'Shea JM, Perkins ND. Thr435 phosphorylation regulates RelA (p65) NF-κB subunit transactivation. Biochem J 2010; 426:345-54.
40. Barre B, Vigneron A, Coqueret O. The STAT3 transcription factor is a target for the Myc and riboblastoma proteins on the Cdc25A promoter. J Biol Chem 2005; 280:15673-81.